Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAMET trial of low-dose aspirin and metformin after resection of stage I-III colorectal cancer
2015-004824-77Phase 2Terminated
- Sponsor
- Ospedali Galliera
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin and metformin in colorectal cancer (CRC) (4 arms), sponsored by Ospedali Galliera. Primary endpoint: Change in NF-kappaB expression in unaffected colonic tissue. Started Jan 2017; status: terminated.
02
Drugs
aspirinmetformin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2015-004824-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004824-77.